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Poster Presentation Abstract:  
Prader-Willi syndrome (PWS) is a multigene disorder commonly associated with hyperphagia and 
obesity. Children with PWS have increased fat mass and decreased lean mass before the onset of 
hyperphagia and obesity. Severe hypotonia and reduced muscle strength are typically present in PWS 
infants. The process of autophagy is essential in maintaining musculoskeletal homeostasis, and 
increased or decreased autophagy can lead to muscle atrophy. Autophagic markers such as ubiquitin 
(Ub), p62/SQSTM1 (p62) and microtubule associated protein 1-light chain 3 (LC3) are hypothesized to be 
connected to the MAGE family of proteins that includes MAGEL2, suggesting that loss of MAGEL2 could 
modulate autophagy in muscle. Expression of Magel2 was detected in the murine nervous system and in 
developing muscle, connective tissue and bone. Immunohistochemistry (IHC), and immunoblotting were 
used to determine whether loss of Magel2 affects the accumulation of autophagic markers or 
expression of genes associated with muscle atrophy, in neonatal mice. The p62 positive aggregates were 
increased in muscle from magel2 mice and atrophy genes were up-regulated. Abnormal autophagic 
processes likely contribute to muscle atrophy in mice lacking Magel2. Further studies are needed to 
determine how the inactivation of Magel2 causes muscle phenotypes at a cellular level. Our mouse 
strain carrying loss of Magel2 provides a model for muscular dysfunction in Prader-Willi syndrome. 
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